Dapagliflozin + Saxagliptin in a Basal-bolus Insulin Treatment
NCT02965443
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class
Stopped
Low patient recruitment
Conditions
Type 2 Diabetes
Interventions
DRUG:
Dapagliflozin 10 mg + Saxagliptin 5 mg
DRUG:
Placebo 1 10 mg + Placebo 2 5 mg
Sponsor
University Hospital Tuebingen